# FDA Inspection 1303154 - MPS Pharma & Medical Inc. - February 13, 2026

Source: https://www.keypedia.com/records/fda_inspections/mps-pharma-medical-inc/d41a04cc-a68a-41b2-a559-e61718785a98
Source feed: FDA_Inspections

> FDA Inspection 1303154 for MPS Pharma & Medical Inc. on February 13, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1303154
- Company Name: MPS Pharma & Medical Inc.
- Inspection Date: 2026-02-13
- Classification: No Action Indicated (NAI)
- Project Area: Postmarket Assurance: Devices
- Product Type: Devices

## Related Documents

- [FDA Inspection 1303154 - 2026-02-13](https://www.keypedia.com/records/fda_inspections/mps-pharma-medical-inc/97ac6d89-8fe8-4249-a3ea-8effe3364d0c)
- [FDA Inspection 1303154 - 2026-02-13](https://www.keypedia.com/records/fda_inspections/mps-pharma-medical-inc/6293bf69-4cbe-499e-a31a-1536f85e4259)
- [FDA Inspection 1303154 - 2026-02-13](https://www.keypedia.com/records/fda_inspections/mps-pharma-medical-inc/9149b904-2a53-418a-a2a6-370193b6d79e)
- [FDA Inspection 1214576 - 2023-07-28](https://www.keypedia.com/records/fda_inspections/mps-pharma-medical-inc/1c4f4e7e-1a71-494c-baf6-a698066df4d9)
- [FDA Inspection 1214576 - 2023-07-28](https://www.keypedia.com/records/fda_inspections/mps-pharma-medical-inc/c77ddf5e-52f0-450e-93ae-c77f2667e572)

Company: https://www.keypedia.com/companies/mps-pharma-medical-inc/f5f20e5d-1743-4f1b-9801-d5d376a19dbb